SciSparc autism trial enrolls 26 of 60 planned children for SCI-210

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. ONON
6. FFAI
7. BA
8. RTB
9. ACN
10. AAPL

Go back to SciSparc autism trial enrolls 26 of 60 planned children for SCI-210
(NASDAQ: SPRC) Delayed: 4.51 --0 (-0%)
Previous Close $4.51    52 Week High $ 
Open $4.51    52 Week Low $ 
Day High $4.51    P/E N/A 
Day Low $4.51    EPS $ 
Volume 18,106